Planet 13 Holdings Inc banner
P

Planet 13 Holdings Inc
CNSX:PLTH

Watchlist Manager
Planet 13 Holdings Inc
CNSX:PLTH
Watchlist
Price: 0.195 CAD -26.42% Market Closed
Market Cap: CA$64m

EV/S

0.4
Current
61%
Cheaper
vs 3-y average of 1

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
0.4
=
Enterprise Value
CA$62.7m
/
Revenue
$103.4m

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
0.4
=
Enterprise Value
CA$62.7m
/
Revenue
$103.4m

Valuation Scenarios

Planet 13 Holdings Inc is trading below its 3-year average

If EV/S returns to its 3-Year Average (1), the stock would be worth CA$0.5 (157% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+798%
Average Upside
470%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 0.4 CA$0.2
0%
3-Year Average 1 CA$0.5
+157%
5-Year Average 1.4 CA$0.7
+258%
Industry Average 3.6 CA$1.75
+798%
Country Average 3 CA$1.5
+667%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
CA$62.7m
/
Jan 2026
$103.4m
=
0.4
Current
CA$62.7m
/
Dec 2026
$94.5m
=
0.7
Forward
CA$62.7m
/
Dec 2027
$101.3m
=
0.6
Forward
CA$62.7m
/
Dec 2028
$103.3m
=
0.6
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close
Market Cap EV/S P/E
US
Planet 13 Holdings Inc
CNSX:PLTH
63.5m CAD 0.4 -0.7
US
Eli Lilly and Co
NYSE:LLY
835.2B USD 13.3 40.5
US
Johnson & Johnson
NYSE:JNJ
547.8B USD 6 26
CH
Roche Holding AG
SIX:ROG
248.4B CHF 4.7 20.1
UK
AstraZeneca PLC
LSE:AZN
216.4B GBP 5.2 28
CH
Novartis AG
SIX:NOVN
223.1B CHF 5.2 19.5
US
Merck & Co Inc
NYSE:MRK
276.9B USD 4.8 15.2
IE
Endo International PLC
LSE:0Y5F
244.4B USD 108.7 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 4.1 11.4
US
Pfizer Inc
NYSE:PFE
153.5B USD 3.2 19.8
US
Bristol-Myers Squibb Co
NYSE:BMY
118.2B USD 3.1 16.8
P/E Multiple
Earnings Growth PEG
US
P
Planet 13 Holdings Inc
CNSX:PLTH
Average P/E: 21.9
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.5
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
26
8%
3.3
CH
Roche Holding AG
SIX:ROG
20.1
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
28
25%
1.1
CH
Novartis AG
SIX:NOVN
19.5
14%
1.4
US
Merck & Co Inc
NYSE:MRK
15.2
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
0%
N/A
US
Pfizer Inc
NYSE:PFE
19.8
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.8
16%
1

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 11 256 companies
5th percentile
0.4
Low
0 — 1.6
Typical Range
1.6 — 5.3
High
5.3 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.6
Median 3
70th Percentile 5.3
Max 4 613 320.1

Planet 13 Holdings Inc
Glance View

Market Cap
64m CAD
Industry
Pharmaceuticals

Planet 13 Holdings, Inc. engages in the manufacture and production of cannabis products. The company is headquartered in Las Vegas, Nevada and currently employs 575 full-time employees. The company went IPO on 2018-06-21. The firm owns and manufactures cannabis products under various brands, including HaHa (gummies and beverages), Dreamland (chocolates), Trendi (vapes and concentrates), Medizin (flower, vapes, concentrates), Leaf and Vine (vapes). Through its subsidiaries in Nevada, it holds six licenses for cultivation (three medical licenses and three recreational licenses), six licenses for production (three medical licenses and three recreational licenses), three dispensary licenses (one medical license and two recreational licenses) and two distribution licenses (one active and one conditional). The company operates two dispensaries in Nevada under two adult-use and one medical licenses. Its manufactured products and Trendi-branded third-party flower are distributed through Nevada under its Nevada distribution license. The firm sells over 123 different strains of cannabis.

PLTH Intrinsic Value
0.326 CAD
Undervaluation 40%
Intrinsic Value
Price CA$0.195
P
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett